45
2
followers
Our mission is to empower biotechnology and personalized medicine with next generation bioinformatics. Our customers are scientists and healthcare practitioners, as well as contract research organizations, providing or setting up preclinical biomarker discovery services. Our customers need a solution to autonomously conduct reproducible research and exploratory data analysis, which is what our innovative cloud bioinformatics analysis apps and e-learning provide. We are developing our activity focusing on a fast-growing niche, the use of next generation sequencing to analyze the microbiome and its interactions with the host in human/animal health and well-being.
GeneCreek has obtained an 8yr zero interest loan from BPI France and the regional FIRA fund and is looking for a seed investment of €1M no later than mid July 2016.
Published 7 years ago
GeneCreek SAS has obtained the Fench national tax refund agreement "Crédit Impôt Recherche" (CIR). This agreement secures our fiscal young innovative company (Jeune Entreprse Innovante - JEI) and also allows legal entities based in France to benefit from tax refunds when subcontracting R&D to GeneCreek. The agreement is valid for 3 years, 2016-2018.
Published 8 years ago
GeneCreek launched its 16S rRNA Profiling offer at the 2nd Translational Microbiome conference in Boston last week.
Microbiome at the bench - therapeutic opportunities in the microbiome
There are no organizations in the network.
